-
Real-world metadata for regulatory purposes workshop
Real-world metadata for regulatory purposes workshop
-
Real-world metadata for regulatory purposes workshop
Real-world metadata for regulatory purposes workshop
Follow our virtual workshop live today, Monday, 12 April, from 13:30 to 18:30 CET
-
PRAC highlights April 2021
PRAC highlights April 2021
-
PRAC highlights April 2021
PRAC highlights April 2021
Outcomes from the April meeting cover all aspects of the risk management of the use of medicines, including COVID-19 vaccines
-
COVID-19 AstraZeneca vaccine - PRAC conclusion
COVID-19 AstraZeneca vaccine - PRAC conclusion
-
COVID-19 AstraZeneca vaccine - PRAC conclusion
COVID-19 AstraZeneca vaccine - PRAC conclusion
EMA’s safety committee (PRAC) has concluded its review of very rare cases of unusual blood clots. The PRAC has recommended further updates to the product information for the vaccine.
-
Public meeting on COVID-19 vaccines
Public meeting on COVID-19 vaccines
-
Public meeting on COVID-19 vaccines
Public meeting on COVID-19 vaccines
A video recording and presentation slides are now available from EMA’s public meeting on COVID-19 vaccines on 26 March.
